| For: | Ma XY, Chen FQ. Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia. World J Clin Cases 2021; 9(33): 10064-10074 [PMID: 34904076 DOI: 10.12998/wjcc.v9.i33.10064] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i33/10064.htm |
| Number | Citing Articles |
| 1 |
Evangelia Constantine, Luke Enthoven, Riley Kahan, Emily M. Pflug, Alexander Lauder. The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Fracture Risk in Overweight or Obese, Nondiabetic Patients. Journal of the American Academy of Orthopaedic Surgeons 2026; 34(12) doi: 10.5435/JAAOS-D-24-01505
|
| 2 |
Ioana Bujdei-Tebeică, Doina Andrada Mihai, Anca Mihaela Pantea-Stoian, Simona Diana Ștefan, Claudiu Stoicescu, Cristian Serafinceanu. Effects of Blood-Glucose Lowering Therapies on Body Composition and Muscle Outcomes in Type 2 Diabetes: A Narrative Review. Medicina 2025; 61(8) doi: 10.3390/medicina61081399
|
| 3 |
Priyanka Prajapati, Anand Kumar, Rishabh Chaudary, Shubhada Mangrulkar, Malti Arya, Sapana Kushwaha. A Comprehensive Review of Essential Aspects of Molecular Pathophysiological
Mechanisms with Emerging Interventions for Sarcopenia in Older People. Current Molecular Pharmacology 2023; 17 doi: 10.2174/1874467216666230308142137
|
| 4 |
Tae Min Kim, Junyoung Park, Kaustuv Roy, Hak Soo Choi, Kang Moo Huh, Eun-Jung Jin, Sung Young Park. Muscle microenvironment-regulated phase transition and microstructure of injectable conductive hydrogel for injured muscle regeneration. Chemical Engineering Journal 2025; 519 doi: 10.1016/j.cej.2025.164847
|
| 5 |
Weena Joongpan, Nittaya Boonmuen, Pimthong Sinchai, Sarawut Lapmanee, Natawat Klamsakul, Nutthapoom Pathomthongtaweechai. The Effects of SGLT2 Inhibitors on Muscle Health in Older Adults: A Systematic Review and Meta‐Analysis. Pharmacology Research & Perspectives 2026; 14(2) doi: 10.1002/prp2.70232
|
| 6 |
Oluwaseun Anyiam, Arash Ardavani, Rushdina Sofia Abdul Rashid, Avinash Panesar, Iskandar Idris. How do glucagon‐like Peptide‐1 receptor agonists affect measures of muscle mass in individuals with, and without, type 2 diabetes: A systematic review and meta‐analysis. Obesity Reviews 2025; 26(7) doi: 10.1111/obr.13916
|
| 7 |
Justyna Rentflejsz, Zyta Beata Wojszel. Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers. Journal of Clinical Medicine 2024; 13(4) doi: 10.3390/jcm13041107
|
| 8 |
Rizwan Qaisar, Asima Karim, Tahir Muhammad, M. Shahid Iqbal, Firdos Ahmad. Metformin Improves Sarcopenia-Related Quality of Life in Geriatric Adults: A Randomized Controlled Trial. Archives of Medical Research 2024; 55(4) doi: 10.1016/j.arcmed.2024.102998
|
| 9 |
Seyedeh Samira Rakhsha, Hossein Shahinfar, Sara Ebrahimi‐Mousavi, Ali Kosari, Yasaman Aali, Atieh Mirzababaei, Seyed Alireza Hosseini, Paria Jadidi, Gita Shafiee, Mohammad Javad MansourZadeh, Ramin Heshmat, Dena Mastouri. Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and Network Meta‐Analysis. Diabetes, Obesity and Metabolism 2026; doi: 10.1111/dom.70957
|
| 10 |
Ever Espino-Gonzalez, Emilie Dalbram, Rémi Mounier, Julien Gondin, Jean Farup, Niels Jessen, Jonas T. Treebak. Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments. Cell Metabolism 2024; 36(6) doi: 10.1016/j.cmet.2024.02.014
|
| 11 |
Mariana Yocelin Cantu-Rodriguez, Dalia Gutierrez-González, Iván Francisco Fernández-Chau, Andrea Treviño-Ferrer, Andrea Vallejo, Ana Sofia Sánchez-García, Christian Reguera-Hernández, Sara Jaqueline Castruita-Von Chong, Carlos Alberto Vázquez-Martínez, Juan Enrique Santos-Macias, Miguel Ángel Sanz-Sanchez, Arnulfo González-Cantú, Maria Elena Romero-Ibarguengoitia. Risk Factors for Sarcopenic Obesity in Adults: A Case-Control Study Using Bioelectrical Impedance Analysis. AACE Endocrinology and Diabetes 2026; doi: 10.1016/j.aed.2026.06.009
|
| 12 |
Yuan Cao, Yulin Li, Wenqiang Han, Xu Jia, Ping Zhu, Bin Wei, Xiaoyan Cong, Zhihao Wang. Sodium Butyrate Ameliorates Type 2 Diabetes-Related Sarcopenia Through IL-33-Independent ILC2s/IL-13/STAT3 Signaling Pathway. Journal of Inflammation Research 2023; doi: 10.2147/JIR.S392350
|
| 13 |
André J. Scheen. GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies. Diabetes & Metabolism 2025; 51(5) doi: 10.1016/j.diabet.2025.101681
|
| 14 |
Meiling She, Minna Huang, Jing Zhang, Yan Yan, Lingli Zhou, Meng Zhang, Yajun Yang, Dongtao Wang. Astragulus embranaceus (Fisch.) Bge-Dioscorea opposita Thunb herb pair ameliorates sarcopenia in senile type 2 diabetes mellitus through Rab5a/mTOR-mediated mitochondrial dysfunction. Journal of Ethnopharmacology 2023; 317 doi: 10.1016/j.jep.2023.116737
|
| 15 |
Irene Caballero-Mateos, Cristóbal Morales-Portillo, Beatriz González Aguilera. Once-Weekly Semaglutide Improves Body Composition in Spanish Obese Adults with Type 2 Diabetes: A 48-Week Prospective Real-Life Study. Journal of Clinical Medicine 2025; 14(15) doi: 10.3390/jcm14155434
|
| 16 |
Jose K. Hernandez Roman, Michael Attanasi, Sanjaya K. Satapathy. Recent Advances in Liver Cirrhosis Related Complications. 2025; doi: 10.1016/B978-0-443-21938-2.00017-5
|
| 17 |
Rizwan Qaisar, Mashal Javed, Imran Muhammad Khan, Firdos Ahmad, Asima Karim. Metformin improves skeletal muscle and physical capacity by stabilizing neuromuscular junction in older adults. Archives of Gerontology and Geriatrics 2024; 127 doi: 10.1016/j.archger.2024.105587
|
| 18 |
Byron J. Hoogwerf. Diabetes and Sarcopenia: Intersection of Co Morbid Conditions. OBM Geriatrics 2025; 9(01) doi: 10.21926/obm.geriatr.2501299
|
| 19 |
Lili Chen, Jinghan Zheng, Bo Ye, Yuxin Huang, Zhenrong Wang. Diabetes and sarcopenia: A bibliometric exploration of mechanisms, comorbidities, and therapeutic frontiers—an evidence mapping study. Experimental Gerontology 2025; 210 doi: 10.1016/j.exger.2025.112874
|
| 20 |
Hiroshi Watanabe, Yutaka Kitazato, Shu Hirashima, Yuki Enoki, Hiromasa Kato, Wataru Ochiai, Hitoshi Maeda, Motoko Tanaka, Kazutaka Matsushita, Toru Maruyama. Organ Crosstalk in CKD-Associated Frailty: Mechanistic Insights, Translational Opportunities, and Clinical Implications. Biological and Pharmaceutical Bulletin 2026; 49(6) doi: 10.1248/bpb.b26-00057
|